AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 68 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,000 | -28.6% | 8,000 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | 0.0% | 8,000 | -25.2% | 0.00% | – |
| Q2 2019 | $7,000 | -46.2% | 10,700 | -31.8% | 0.00% | – |
| Q1 2019 | $13,000 | -13.3% | 15,700 | +71.6% | 0.00% | – |
| Q4 2018 | $15,000 | -55.9% | 9,150 | -11.6% | 0.00% | – |
| Q3 2018 | $34,000 | +88.9% | 10,352 | +29.4% | 0.00% | – |
| Q2 2018 | $18,000 | – | 8,002 | +3220.3% | 0.00% | – |
| Q3 2015 | $0 | – | 241 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 241 | -98.9% | 0.00% | – |
| Q3 2013 | $45,000 | -48.9% | 22,204 | -36.6% | 0.00% | – |
| Q2 2013 | $88,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |